2016 American Transplant Congress

Tuesday, June 14, 2016

6:00pm-7:00pm

Epidemiology of Surgical Site Infections After Liver Transplantation: 4 Year Prospective Study.

Y. Natori, R. Kassar, A. Iaboni, S. Hosseini-Moghaddam, D. Vu, S. Husain, E. Renner, C. Rotstein.

Poster Session D: Fungi, PJP, Mycobacteria, Infection Risk Factors, Vaccination and Donor Derived Infections  •  Halls C&D

6:00pm-7:00pm

ESM1 Gene Promotes Hepatocyte Proliferation Through NF-κB Signal Pathway.

J. Zhou, W. Ju, X. Jiao, X. Zhu, X. He.

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D

6:00pm-7:00pm

Establishment of SCID Pigs Cell Lines to Prevent Immunodeficiency Using RGEN System.

D.-H. Kim,¹ J.-S. Ahn,¹ S. Hwang,² J.-W. Lee.¹

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D

6:00pm-7:00pm

Evaluating the Influence of Liver Donor and Recipient Race on Tacrolimus Dose Requirements.

J. Knorr, J. Vidal, V. Navarro, R. Zaki.

Poster Session D: Liver: Immunosuppression and Rejection  •  Halls C&D

6:00pm-7:00pm

Evaluation of Long Term Outcome After Living Donor Liver Transplantation in Sequential 653 Recipients with or without Viral Infection: Is HBV & HCV Co-Infection Better Than the Monoinfection? A Single Center Retrospective Analysis.

H. Yang, A. Thorat, L. Jeng, C.-C. Yeh, T.-H. Chen, S.-C. Hsu, K.-S. Poon.

Poster Session D: Viral Hepatitis  •  Halls C&D

6:00pm-7:00pm

Evaluation of Patient-Reported Nonadherence with Tacrolimus Level Variability in Renal Transplant Recipients.

N. Parrish,¹ T. Kaiser,² A. McCann,¹ J. Aladimi,² J. Harris,³ A. Govil,² B. Abu Jawdeh,² G. Mogilishetty,² R. Alloway,² E. Woodle.²

Poster Session D: Psychosocial and Treatment Adherence  •  Halls C&D

6:00pm-7:00pm

Evaluation of Polyomavirus (BK) Treatment and Clinical Outcomes in Pediatric Kidney Transplant Recipients: A >10 Year Single Center Retrospective Experience.

R. Liverman,¹ E. Kraus,¹ R. Garro,² B. Warshaw,² P. Winterberg,² R. George.²

Poster Session D: Polyomavirus  •  Halls C&D

6:00pm-7:00pm

Evaluation of the Utilization of Filgrastim in Kidney Transplant Recipients.

T. Poon,¹ C. Guerra.²

Poster Session D: Poster Session II: Kidney Complications-Other  •  Halls C&D

6:00pm-7:00pm

Everolimus Abrogates C5a and TGFβ Mediated Perycite-to-Myofibroblast Transition (PMT) Inhibiting Vascular Rarefaction.

G. Castellano, R. Franzin, A. Stasi, C. Divella, L. Gesualdo.

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D

6:00pm-7:00pm

Excellent Results of Living-Related Renal Transplant Recipients Treated with High-Dose Mizoribine – Comparison of Taclorimus with CsA for Two Years Result by a Japanese Multicenter Study.

N. Yoshimura, K. Nishimura, K. Akioka, M. Shimazu, K. Nose, T. Nishioka, N. Nakamura, K. Uchida, T. Nakatani, H. Ushigome.

Poster Session D: Kidney Immunosuppression: Novel Agents  •  Halls C&D